Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse
Moskowitz, Craig H., Walewski, Jan, Nademanee, Auayporn, Masszi, Tamas, Agura, Edward, Holowiecki, Jerzy, Abidi, Muneer H., Chen, Andy I., Stiff, Patrick, Viviani, Simonetta, Bachanova, Veronika, Sureda, Anna, McClendon, Teresa, Lee, Connie, Lisano, Julie, Sweetenham, John
Published in Blood (20.12.2018)
Published in Blood (20.12.2018)
Get full text
Journal Article
Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma
Santoro, Armando, Moskowitz, Alison J., Ferrari, Silvia, Carlo-Stella, Carmelo, Lisano, Julie, Francis, Stephen, Wen, Rachael, Akyol, Alev, Savage, Kerry J.
Published in Blood (01.06.2023)
Published in Blood (01.06.2023)
Get full text
Journal Article
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus
Gru, Alejandro A, Lim, Megan S, Dogan, Ahmet, Horwitz, Steven M, Delabie, Jan, Fu, Kai, Peker, Deniz, Reddy, Vishnu V B, Xu, Mina L, Vij, Kiran, Slack, Graham W, Miranda, Roberto N, Jagadeesh, Deepa, Lisano, Julie M, Hsi, Eric D, Torlakovic, Emina
Published in Archives of pathology & laboratory medicine (1976) (01.01.2023)
Published in Archives of pathology & laboratory medicine (1976) (01.01.2023)
Get full text
Journal Article
Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma
Jagadeesh, Deepa, Horwitz, Steve, Bartlett, Nancy L, Kim, Youn, Jacobsen, Eric, Duvic, Madeleine, Little, Meredith, Trepicchio, William, Fenton, Keenan, Onsum, Matthew, Lisano, Julie, Advani, Ranjana
Published in The oncologist (Dayton, Ohio) (01.10.2022)
Published in The oncologist (Dayton, Ohio) (01.10.2022)
Get full text
Journal Article
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults
Harker-Murray, Paul, Mauz-Körholz, Christine, Leblanc, Thierry, Mascarin, Maurizio, Michel, Gérard, Cooper, Stacy, Beishuizen, Auke, Leger, Kasey J., Amoroso, Loredana, Buffardi, Salvatore, Rigaud, Charlotte, Hoppe, Bradford S., Lisano, Julie, Francis, Stephen, Sacchi, Mariana, Cole, Peter D., Drachtman, Richard A., Kelly, Kara M., Daw, Stephen
Published in Blood (27.04.2023)
Published in Blood (27.04.2023)
Get full text
Journal Article
Economic assessment of diagnostic revision in peripheral T-cell lymphoma
Lisano, Julie M., Liu, Nicholas, Yu-Isenberg, Kristina, Singh, Deepak, Campbell, David, Su, Wayne
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy
Burke, John M, Liu, Nicholas, Yu, Kristina S, Fanale, Michelle A, Surinach, Andy, Flores, Carlos, Lisano, Julie, Phillips, Tycel
Published in The oncologist (Dayton, Ohio) (01.06.2023)
Published in The oncologist (Dayton, Ohio) (01.06.2023)
Get full text
Journal Article
Real-World Treatment Patterns and Overall Survival Among Medicare Fee-for-Service Beneficiaries Newly Diagnosed with Peripheral T-Cell Lymphoma
Shah, Anne, Petrilla, Allison, Rebeira, Mayvis, Feliciano, Joseph, LeBlanc, Thomas W., Lisano, Julie
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Real-World Characteristics of Patients with Classical Hodgkin Lymphoma Receiving Frontline Brentuximab Vedotin with Chemotherapy: A Retrospective Analysis with Propensity Score Matching
Phillips, Tycel J., Yu-Isenberg, Kristina, Liu, Nicholas, Surinach, Andy, Flores, Carlos, Lisano, Julie, Fanale, Michelle A., Burke, John M.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Real-World Characteristics of Patients with Peripheral T-Cell Lymphoma Receiving Frontline Brentuximab Vedotin with Chemotherapy: A Retrospective Analysis with Propensity Score Matching
Burke, John M., Liu, Nicholas, Yu-Isenberg, Kristina, Fanale, Michelle A., Surinach, Andy, Flores, Carlos, Lisano, Julie, Phillips, Tycel J.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Cost-Effectiveness of Brentuximab Vedotin Versus Physician’s Choice of Methotrexate or Bexarotene for the Treatment of Cutaneous T-cell Lymphoma in Canada
Elsea, David, Savage, Kerry J., Lilley, Cameron, Lisano, Julie, Liu, Jingmin, Yu, Kristina S.
Published in Advances in therapy (01.05.2023)
Published in Advances in therapy (01.05.2023)
Get full text
Journal Article
Real World Prevalence of Diagnostic Revision Among Patients with Peripheral T-Cell Lymphomas (PTCL) in the US: Results of an Administrative Claims and Electronic Medical Record Analyses
Feliciano, Joseph, Bonafede, Machaon, McMorrow, Donna, Park, Julie, Lisano, Julie, Manley, Thomas
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Response to brentuximab vedotin versus physician’s choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis
Kim, Youn H., Prince, H. Miles, Whittaker, Sean, Horwitz, Steven M., Duvic, Madeleine, Bechter, Oliver, Sanches, Jose A., Stadler, Rudolf, Scarisbrick, Julia, Quaglino, Pietro, Zinzani, Pier Luigi, Wolter, Pascal, Eradat, Herbert, Pinter-Brown, Lauren C., Ortiz-Romero, Pablo L., Akilov, Oleg E., Trotman, Judith, Taylor, Kerry, Weichenthal, Michael, Walewski, Jan, Fisher, David, McNeeley, Marise, Gru, Alejandro A., Brown, Lisa, Palanca-Wessels, M. Corinna, Lisano, Julie, Onsum, Matthew, Bunn, Veronica, Little, Meredith, Trepicchio, William L., Dummer, Reinhard
Published in European journal of cancer (1990) (01.05.2021)
Published in European journal of cancer (1990) (01.05.2021)
Get full text
Journal Article
Health Care Resource Utilization and Costs Among Medicare Beneficiaries Newly Diagnosed With Peripheral T-cell Lymphoma: A Retrospective Claims Analysis
Shah, Anne, Petrilla, Allison, Rebeira, Mayvis, Feliciano, Joseph, Lisano, Julie, LeBlanc, Thomas W.
Published in Clinical lymphoma, myeloma and leukemia (01.01.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.01.2021)
Get full text
Journal Article
Cost-effectiveness of brentuximab vedotin plus chemotherapy for previously untreated CD30-positive peripheral T-cell lymphoma in Canada
Zou, Denise, Lee, Joseph, Kansal, Anuraag, Ma, Wenkang, Harris, Mack, Lisano, Julie, Fenton, Keenan, Yu, Kristina S.
Published in Journal of medical economics (31.12.2022)
Published in Journal of medical economics (31.12.2022)
Get full text
Journal Article
Nivolumab, Brentuximab Vedotin, +/- Bendamustine For R/R Hodgkin Lymphoma in Children, Adolescents, and Young Adults
Harker-Murray, Paul, Mauz-Körholz, Christine, Leblanc, Thierry M, Mascarin, Maurizio, Michel, Gérard, Cooper, Stacy, Beishuizen, Auke, Leger, Kasey J., Amoroso, Loredana, Buffardi, Salvatore, Rigaud, Charlotte, Hoppe, Bradford S., Lisano, Julie M, Francis, Stephen, Sacchi, Mariana, Cole, Peter D., Drachtman, Richard A., Kelly, Kara M., Daw, Stephen
Published in Blood (23.12.2022)
Published in Blood (23.12.2022)
Get full text
Journal Article
Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study
Dummer, Reinhard, Prince, Henry M., Whittaker, Sean, Horwitz, Steven M., Kim, Youn H., Scarisbrick, Julia, Quaglino, Pietro, Zinzani, Pier Luigi, Wolter, Pascal, Eradat, Herbert, Pinter-Brown, Lauren, Sanches, Jose A., Ortiz-Romero, Pablo L., Akilov, Oleg E., Geskin, Larisa, Huen, Auris, Walewski, Jan, Wang, Yinghui, Lisano, Julie, Richhariya, Akshara, Feliciano, Joseph, Zhu, Yanyan, Bunn, Veronica, Little, Meredith, Zagadailov, Erin, Dalal, Mehul R., Duvic, Madeleine
Published in European journal of cancer (1990) (01.07.2020)
Published in European journal of cancer (1990) (01.07.2020)
Get full text
Journal Article
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
Horwitz, Steven M., Scarisbrick, Julia J., Dummer, Reinhard, Whittaker, Sean, Duvic, Madeleine, Kim, Youn H., Quaglino, Pietro, Zinzani, Pier Luigi, Bechter, Oliver, Eradat, Herbert, Pinter-Brown, Lauren, Akilov, Oleg E., Geskin, Larisa, Sanches, Jose A., Ortiz-Romero, Pablo L., Weichenthal, Michael, Fisher, David C., Walewski, Jan, Trotman, Judith, Taylor, Kerry, Dalle, Stephane, Stadler, Rudolf, Lisano, Julie, Bunn, Veronica, Little, Meredith, Prince, H. Miles
Published in Blood advances (14.12.2021)
Published in Blood advances (14.12.2021)
Get full text
Journal Article
Brentuximab vedotin (BV) versus physician’s choice (PC) of methotrexate or bexarotene in adult patients with previously treated CD30-positive cutaneous T-cell lymphoma (CTCL; mycosis fungoides [MF] or primary cutaneous anaplastic large cell lymphoma [pcALCL]): final time to next therapy (TTNT) results from the phase 3 ALCANZA study
Scarisbrick, Julia, Horwitz, Steven M., Prince, H. Miles, Whittaker, Sean, Duvic, Madeleine, Kim, Youn H., Quaglino, Pietro, Zinzani, Pier Luigi, Bechter, Oliver, Eradat, Herbert, Pinter-Brown, Lauren, Akilov, Oleg, Geskin, Larisa, Sanches, Jose, Ortiz-Romero, Pablo, Lisano, Julie, Brown, Lisa, Bunn, Veronica, Little, Meredith, Dummer, Reinhard
Published in European journal of cancer (1990) (2019)
Published in European journal of cancer (1990) (2019)
Get full text
Journal Article